Impacts

Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease

Claude Wischik (Participant), Charles Harrington (Participant), John Storey (Participant), Janet Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven Kemp (Participant), James Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant) & C Marshall (Participant)

Impact: Quality of life Impacts, Economic Impacts

International Standards for Portland-Limestone Cements

Fredrik Paul Glasser (Coordinator) & Donald MacPhee (Coordinator)

Impact